Effect modification of the association between comorbidities and severe course of COVID-19 disease by age of study participants: a systematic review and meta-analysis.
dc.contributor.author | Fernández Villalobos, Nathalie Verónica | |
dc.contributor.author | Ott, Jördis Jennifer | |
dc.contributor.author | Klett-Tammen, Carolina Judith | |
dc.contributor.author | Bockey, Annabelle | |
dc.contributor.author | Vanella, Patrizio | |
dc.contributor.author | Krause, Gérard | |
dc.contributor.author | Lange, Berit | |
dc.date.accessioned | 2021-07-08T13:49:57Z | |
dc.date.available | 2021-07-08T13:49:57Z | |
dc.date.issued | 2021-06-30 | |
dc.identifier.citation | Syst Rev. 2021 Jun 30;10(1):194. doi: 10.1186/s13643-021-01732-3. | en_US |
dc.identifier.pmid | 34193261 | |
dc.identifier.doi | 10.1186/s13643-021-01732-3 | |
dc.identifier.uri | http://hdl.handle.net/10033/622931 | |
dc.description.abstract | Adjusting the protecting group strategy, from an alkyl ether to a bidentate ketal at the carbohydrate backbone of uridine, facilitates a switchable diastereoselective α- or β-C4'/C5'-spirocyclopropanation. Using these spirocyclopropanated nucleosides as key intermediates, we synthesized a variety of C4'-methylated d-ribose and l-lyxose-configured uridine derivatives by a base-mediated ring-opening of the spirocyclopropanol moiety. Investigations of antiviral activity against the human respiratory syncytial virus were carried out for selected derivatives, showing moderate activity. | en_US |
dc.language.iso | en | en_US |
dc.publisher | BMC | en_US |
dc.relation | nfo:eu-repo/grantAgreement/EC/H2020/101003480 | en_US |
dc.rights | openAccess | en_US |
dc.rights | Attribution 4.0 International | * |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | * |
dc.subject | COVID-19-associated hospitalisation | en_US |
dc.subject | COVID-19-associated mortality | en_US |
dc.subject | Comorbidity | en_US |
dc.subject | Effect modification | en_US |
dc.subject | Interaction | en_US |
dc.subject | Meta-analyses | en_US |
dc.title | Effect modification of the association between comorbidities and severe course of COVID-19 disease by age of study participants: a systematic review and meta-analysis. | en_US |
dc.type | Article | en_US |
dc.identifier.eissn | 2046-4053 | |
dc.contributor.department | HZI,Helmholtz-Zentrum für Infektionsforschung GmbH, Inhoffenstr. 7,38124 Braunschweig, Germany. | en_US |
dc.identifier.journal | Systematic reviews | en_US |
dc.source.volume | 10 | |
dc.source.issue | 1 | |
dc.source.beginpage | 194 | |
dc.source.endpage | ||
refterms.dateFOA | 2021-07-08T13:49:57Z | |
dc.source.journaltitle | Systematic reviews | |
dc.source.country | England |